[HTML][HTML] Enoxaparin

A Jupalli, AM Iqbal - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives: Describe the therapeutic mechanism of action of enoxaparin. Review the many
indications for enoxaparin use. Summarize the adverse event profile of enoxaparin use …

Enoxaparin for VTE thromboprophylaxis during inpatient rehabilitation care: assessment of the standard fixed dosing regimen

A Haim, O Avnery, D Rubin-Asher, H Amir… - BMC Pharmacology and …, 2024 - Springer
Background We aimed to examine the efficiency of fixed daily dose enoxaparin (40 mg)
thromboprophylaxis strategy for patients undergoing inpatient rehabilitation. Methods This …

Effectiveness of apixaban versus enoxaparin in preventing wound complications and deep venous thrombosis following total knee replacement surgery: A …

M Ali Hasan, M Azeez Alsaadi… - … Journal of Clinical …, 2021 - Wiley Online Library
Background Enoxaparin, a thromboprophylactic drug that is widely used for preventing deep
venous thrombosis (DVT) and surgical wound complications after total knee replacement …

New options for anticoagulation in congenital and pediatric acquired heart disease

JR Linder, LM Andrade, TM Giglia, AC Glatz - Progress in Pediatric …, 2020 - Elsevier
Commonly used pediatric anticoagulants include unfractionated heparin, low molecular
weight heparin, and vitamin K antagonists. Their use in pediatrics continues to be …

Enoxaparin for VTE thromboprophylaxis for inpatient rehabilitation care: assessment of the standard fixed dosing regimen

A Haim, O Avnery, D Asher, H Amir, K Hashem, HB Zvi… - 2023 - researchsquare.com
Background. We aimed to examine the efficiency of fixed daily dose enoxaparin (40 mg)
thromboprophylaxis strategy for patients undergoing inpatient rehabilitation. Methods. This …

[PDF][PDF] New Options for Anticoagulation in Congenital and Pediatric Acquired Heart Disease

LM Andrade, TM Giglia - academia.edu
Commonly used pediatric anticoagulants include unfractionated heparin, low molecular
weight heparin and vitamin K antagonists. Their use in pediatrics continues to be …

Evaluation of Anticoagulant Monitoring in Pediatric Patients Receiving Enoxaparin for Treatment of Venous Thrombosis

J Koury, R Hellinga, J Rose… - The Journal of …, 2021 - meridian.allenpress.com
OBJECTIVES A venous thromboembolism (VTE) is a blood clot that occurs secondary to
vessel wall injury often from a central line insertion. Enoxaparin is often considered a first …

P45 Enoxaparin and tinzaparin in pediatrics: impact of prescription recommendations on prescription quality and anti-Xa levels

J Noailly, L Sadozaï, MF Hurtaud-Roux, J Naudin… - 2020 - adc.bmj.com
Aims Enoxaparin and tinzaparin, two low-molecular-weight heparins (LMWH), are used in
paediatrics with multiples advantages such as facility of administration, reduced frequency of …

[HTML][HTML] Anticoagulant and Fibrinolytic Therapy (FL INITIAL Autonomous Practice-Pharmacology)

D Bartlett - ceufast.com
Anticoagulant and Fibrinolytic Therapy | Nursing CEU | CEUfast CEUfast Logo Settings
View All Notifications MENU Sign Up Login Courses Find your courses See state …

[HTML][HTML] Continuing Education Activity

A Jupalli, AM Iqbal - europepmc.org
Objectives: Describe the therapeutic mechanism of action of enoxaparin. Review the many
indications for enoxaparin use. Summarize the adverse event profile of enoxaparin use …